Diagnostic utility of the risk of malignancy index for borderline ovarian tumors

被引:0
|
作者
Oh, So Ra [1 ]
Park, Jung-Woo [1 ]
机构
[1] Dong A Univ, Med Ctr, Dept Obstet & Gynecol, Coll Med, Busan, South Korea
关键词
Borderline ovarian tumor; Risk of malignancy index; Diagnosis; MENOPAUSAL STATUS; PREOPERATIVE EVALUATION; CLINICAL MANAGEMENT; ADNEXAL MASSES; PELVIC MASSES; CANCER; ULTRASOUND; CA125; POPULATION; NEOPLASMS;
D O I
10.12892/ejgo4006.2018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of investigation: To determine the best cutoff value for the risk of malignancy index (RMI) by comparing the four malignancy risk indices (RMI 1, RMI 2, RMI 3, and RMI 4) in patients with borderline ovarian tumors (BOTs). Materials and Methods: The authors enrolled 510 patients in this retrospective study: 76 women with BOTs and 434 with benign adnexal masses. There were no restrictions in BOT histotypes. Results: The area under the curves for RMI 1, RMI 2, RMI 3, and RMI 4 were 0.742, 0.755, 0.765, and 0.787, respectively. RMI 4 performed better in diagnosing BOT preoperatively than RMI 1, RMI 2, and RMI 3, at a cutoff value of 190. Conclusion: RMI 4 at a cutoff value of 190 can be successfully used for identifying patients with suspected BOTs who require specialist referral.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [41] Borderline ovarian tumors
    Meinhold-Heerlein, I
    GYNAKOLOGE, 2014, 47 (12): : 951 - 959
  • [42] Borderline ovarian tumors
    Link, CJ
    Reed, E
    Sarosy, G
    Kohn, EC
    AMERICAN JOURNAL OF MEDICINE, 1996, 101 (02): : 217 - 225
  • [43] Borderline ovarian tumors
    Darai, E
    Teboul, J
    Walker-Combrouze, F
    Fauconnier, A
    Benifla, JL
    Meneux, E
    Panel, P
    Benzakine, Y
    Tardif, D
    Madelenat, P
    CONTRACEPTION FERTILITE SEXUALITE, 1997, 25 (12): : 933 - 938
  • [44] Borderline ovarian tumors
    Baak, JPA
    van Diest, PJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (07) : 904 - 905
  • [45] Borderline ovarian tumors
    Wenners, A.
    Bauer, M.
    Strauss, A.
    Hilpert, F.
    GYNAKOLOGE, 2012, 45 (04): : 296 - 303
  • [46] Diagnostic Accuracy of Risk of Malignancy Index (RMI) in Discrimination of Benign from Malignant Ovarian Masses
    Liaquat, Farah
    Abbas, Hafiza Yasmeen
    Ali, Nazish
    Waheed, Aliya
    Ghafoor, Saira
    Tahir, Adila
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (04): : 1170 - 1172
  • [47] Borderline ovarian tumors
    Ghaemmaghami, Fatemeh
    Ashraf-Ganjooie, Tahereh
    Iravanloo, Gin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2007, 3 (01) : 12 - 18
  • [48] Ultrasonographic Scoring and Risk of Malignancy Index in Preoperative Prediction of Ovarian Malignancy
    Dasari, Papa
    Pannirselvan, Catherine Leela
    Sridhar, M. G.
    JOURNAL OF GYNECOLOGIC SURGERY, 2013, 29 (02) : 61 - 64
  • [49] COMPARISON OF ROMA (RISK OF OVARIAN MALIGNANCY ALGORITHM), RMI (RISK OF MALIGNANCY INDEX) AND OTI (OVARIAN TUMOR INDEX) IN PATIENTS WITH ADNEXAL MASS
    Ikiz, N.
    Guvenal, T.
    Taneli, F.
    Koyuncu, F. M.
    Kandiloglu, A. R.
    Bilge, S.
    Koltan, S. O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [50] RISK OF OVARIAN MALIGNANCY ALGORITHM IN THE PREOPERATIVE DIAGNOSING OF PATIENTS WITH OVARIAN TUMORS
    Janas, L.
    Glowacka, E.
    Wilczynski, J.
    Malinowski, A.
    Nowak, M.
    ANNALS OF ONCOLOGY, 2014, 25